Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.

Annals of oncology : official journal of the European Society for Medical Oncology - 1 Apr 2015

Findlay J M, Middleton M R, Tomlinson I

Abstract excerpt

INTRODUCTION: There is an urgent need for biomarkers to help predict prognosis and guide management of esophageal cancer. This review identifies, evaluates and meta-analyses the evidence for reported somatic and germline DNA sequence biomarkers of outcome and stage. METHODS: A systematic review was carried out of the PubMed, EMBASE and Cochrane databases (20 August 2014), in conjunction with the ASCO Level of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Esophageal Neoplasms

Share to TYMS gene

Share to Germ-Line Mutation

Share to Neoplasm Staging

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 25214541
DOI: 10.1093/annonc/mdu449
PMCID: PMC4374384

Genes

ERCC1
ABCB1
CCND1
ERBB2
ERCC2
FGF3
MDM2
MTHFR
TYMS
XRCC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.PMID 25214541Read ↗

Germline and somatic genetic predictors of pathological response in neoadjuvant settings of rectal and esophageal cancers: systematic review and meta-analysis.Semantic proximity Read ↗

Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1.Semantic proximity Read ↗

Esophageal cancer: Risk factors, genetic association, and treatment.Semantic proximity Read ↗

Predictive genetic markers in neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: a long way to go. Review of the literature.Semantic proximity Read ↗

Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer.Semantic proximity Read ↗

Molecular characteristics and clinical outcomes of patients with gastroesophageal cancer diagnosed at ages younger than 50 years.Semantic proximity Read ↗

Genomics of Esophageal Cancer and Biomarkers for Early Detection.Semantic proximity Read ↗

Genetic variations in esophageal cancer risk and prognosis.Semantic proximity Read ↗

Molecular Prognostic Factors in Adenocarcinoma of the Esophagus and Gastroesophageal JunctionSemantic proximity Read ↗

Esophageal cancer mutational signatures around the world.Semantic proximity Read ↗

Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.Semantic proximity Read ↗

Tumor profiling of gastric and esophageal carcinoma reveal different treatment options.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.